Clinical Assessment of Cardiovascular Effects and Intubating Conditions with Rocuronium, Vecuronium, and Suxamethonium

Academia Anesthesiologica International

View Publication Info
 
 
Field Value
 
Title Clinical Assessment of Cardiovascular Effects and Intubating Conditions with Rocuronium, Vecuronium, and Suxamethonium
 
Creator Ramesh , Chinta
Varaprasad P Dora
D.S.S.K. Raju
 
Subject Anaesthesia
Endotracheal Intubation
Rocuronium
Suxamenthonium
Vecuronium
 
Description Background: Achieving muscle relaxation during endotracheal intubation is a vital requirement and needs drugs safer than suxamethonium that is early-onset, long duration, stable hemodynamic parameter, minimum side effects, and good intubating conditions. The aims the present study was conducted to evaluate cardiovascular effects and intubating conditions of drug rocuronium compared to vecuronium and suxamethonium. Subjects and Methods: A total of 120 subjects were randomly divided into 3 groups of 40 subjects each depending on muscle relaxant given during intubation as Group I with 0.6 mg/kg rocuronium, Group II with 1.5 mg/kg suxamethonium, and Group III with 0.08 mg/kg vecuronium. Premedication was done with 0.2 mg glycopyrrolate and the anesthetic agent used was 4-5 mg/kg thiopentone sodium 2.5% along with the intermitted injection of vecuronium. Parameters assessed were fasciculations, cardiovascular response, limb movement, coughing, vocal cord movement and position, jaw relaxation, and apnoea onset. Results: For Group I, onset was longer compared to Group II, however, it was lesser than Group III. No fasciculation was seen in Group I and III but was seen in Group II. Better intubating conditions were seen in Group III.    No complication was seen in any subject from any group. Conclusion: The present study concludes that rocuronium is an effective and safer alternative to suxamethonium in tracheal intubation cases in subjects not needing rapid spontaneous respiration return. Hence, it can act as a filler between non-depolarizing neuromuscular blocking agents and suxamethonium and can be considered as the ideal neuromuscular agent.
 
Publisher Society for Health Care & Research Development
 
Date 2021-12-31
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
 
Format application/pdf
application/xml
text/html
application/epub+zip
 
Identifier https://aijournals.com/index.php/aan/article/view/2196
 
Source Academia Anesthesiologica International; Vol 6 No 2 (2021): July-December 2021; 41-44
2456-7388
2617-5479
 
Language eng
 
Relation https://aijournals.com/index.php/aan/article/view/2196/2890
https://aijournals.com/index.php/aan/article/view/2196/2891
https://aijournals.com/index.php/aan/article/view/2196/2892
https://aijournals.com/index.php/aan/article/view/2196/2893
 
Rights Copyright (c) 2021 Author
https://creativecommons.org/licenses/by/4.0/
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library